What is the Krishna Institute of Medical Sciences PE ratio today?
Krishna Institute of Medical Sciences' PE ratio is 144.3 at the 29 October 2026 close (₹702.50 a share): a market capitalisation of ₹29,505 crore divided by consolidated net profit attributable to shareholders of ₹205 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹241 crore) it is 122.2.
What is the Krishna Institute of Medical Sciences PB ratio (price to book value)?
Krishna Institute of Medical Sciences' price-to-book (PB) ratio is 13.13 at the 29 October 2026 close: a market capitalisation of ₹29,505 crore divided by shareholders' equity (book value) of ₹2,247 crore on 31 March 2026. That is a book value of ₹53.51 per share against a share price of ₹702.50.
What is the Krishna Institute of Medical Sciences net worth?
Krishna Institute of Medical Sciences' net worth — shareholders' equity in its consolidated balance sheet — was ₹2,247 crore on 31 March 2026, up 5.1% from ₹2,138 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹29,505 crore at the 29 October 2026 close.
What is the Krishna Institute of Medical Sciences market cap?
Krishna Institute of Medical Sciences' market capitalisation was ₹29,505 crore at the 29 October 2026 close: 42 crore shares at ₹702.50 each.
What is the Krishna Institute of Medical Sciences debt to equity ratio?
Krishna Institute of Medical Sciences' debt-to-equity ratio was 1.27 on 31 March 2026: borrowings of ₹3,244 crore against total equity of ₹2,559 crore. A year earlier, on 31 March 2025, it was 1.06.
What is the Krishna Institute of Medical Sciences EPS?
Krishna Institute of Medical Sciences' basic earnings per share (EPS) were ₹6.03 in FY26, against ₹9.61 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹5.10.
Is Krishna Institute of Medical Sciences debt free?
No. Krishna Institute of Medical Sciences had borrowings of ₹3,244 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.27. Its cash and current investments were ₹89.8 crore, so its net debt was ₹3,154 crore.
What is the Krishna Institute of Medical Sciences book value per share?
Krishna Institute of Medical Sciences' book value per share was ₹53.51 on 31 March 2026: shareholders' equity of ₹2,247 crore divided by the 42 crore shares in issue, up 0.1% from ₹53.45 a year earlier. The share price at the 29 October 2026 close was ₹702.50.
What is the Krishna Institute of Medical Sciences promoter holding?
Promoters held 32.66% of Krishna Institute of Medical Sciences on 30 September 2026, up 0.16 percentage points from 32.50% the previous quarter and down 1.45 percentage points from 34.11% a year earlier, according to the shareholding pattern filed with NSE.
What is the Krishna Institute of Medical Sciences ROE and ROCE?
In FY26, Krishna Institute of Medical Sciences' return on equity (ROE) was 11.0% and its return on capital employed (ROCE) was 9.1%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 19.4% and ROCE 14.6%.
What is the Krishna Institute of Medical Sciences shareholding pattern?
On 30 September 2026, Krishna Institute of Medical Sciences' shares were held by promoters 32.66%, foreign portfolio investors (FII/FPI) 15.01%, domestic institutions (DII) 33.22% (including mutual funds at 28.21%) and retail and other non-institutional investors 19.11%. Over the year, FII holding was down 0.02 percentage points from 15.03% and DII holding was up 1.10 percentage points from 32.12%.
How does the Krishna Institute of Medical Sciences PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Krishna Institute of Medical Sciences' PE ratio is 122.2, the highest of the four: Apollo Hospitals Enterprise 60.7, Max Healthcare Institute 57.4 and Fortis Healthcare 54.7, a peer average of 57.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
What is the Krishna Institute of Medical Sciences free cash flow?
In FY26, Krishna Institute of Medical Sciences generated ₹511 crore of cash from operations and spent ₹1,428 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹917 crore. In FY25 it was −₹427 crore.
What are the Krishna Institute of Medical Sciences latest quarterly results?
Krishna Institute of Medical Sciences' latest results are for Q1 FY27 (April–June 2026), filed on 3 August 2026: consolidated net profit attributable to shareholders ₹41.5 crore, down 47.2% from ₹78.6 crore in Q1 FY26; revenue from operations ₹1,180 crore, up 35.3% year on year.
What is the Krishna Institute of Medical Sciences revenue and profit in FY26?
In FY26 (April 2025–March 2026), Krishna Institute of Medical Sciences' consolidated net profit attributable to shareholders was ₹241 crore, down 37.2% from ₹385 crore in FY25, on revenue from operations of ₹3,905 crore (up 28.6%). Over three years, from FY23, net profit was down 28.2%.
When are the Krishna Institute of Medical Sciences next results?
Krishna Institute of Medical Sciences will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
How does Krishna Institute of Medical Sciences compare with its peers?
On FY26 consolidated figures, against Apollo Hospitals Enterprise, Max Healthcare Institute and Fortis Healthcare: Krishna Institute of Medical Sciences' operating margin of 13.3% is the third highest of the four (Apollo Hospitals Enterprise 11.5%, Max Healthcare Institute 21.5%, Fortis Healthcare 17.9%; peer average 16.9%); its return on equity of 11.0% is the lowest of the four (Apollo Hospitals Enterprise 22.0%, Max Healthcare Institute 14.3%, Fortis Healthcare 11.1%; peer average 15.8%); its revenue growth over three years of 21.1% a year is the second highest of the four (Apollo Hospitals Enterprise 14.9% a year, Max Healthcare Institute 22.4% a year, Fortis Healthcare 13.2% a year; peer average 16.8% a year).
Krishna Institute of Medical Sciences vs Apollo Hospitals Enterprise: how do they compare?
In FY26, Krishna Institute of Medical Sciences earned net profit attributable to shareholders of ₹241 crore on revenue of ₹3,905 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Krishna Institute of Medical Sciences' operating margin was 13.3% (Apollo Hospitals Enterprise 11.5%) and its return on equity 11.0% (Apollo Hospitals Enterprise 22.0%). At the 29 October 2026 close, Krishna Institute of Medical Sciences' market capitalisation was ₹29,505 crore against ₹1,17,916 crore for Apollo Hospitals Enterprise, and its PE ratio on FY26 profit 122.2 against 60.7.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
